Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
Be 'active' in the market while NOT being tied to your desk.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.26% | 87.92 | 1.3% | $848.13m | |
| BIIB | Biogen Inc. | 1.02% | 222.50 | 1.3% | $586.68m | |
| AMGN | Amgen Inc. | -0.06% | 186.59 | 1.2% | $533.06m | |
| ONCE | Spark Therapeutics, Inc. | 0.47% | 113.53 | 11.2% | $497.94m | |
| GILD | Gilead Sciences, Inc. | 0.03% | 63.79 | 0.9% | $468.70m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.82% | 395.00 | 2.6% | $283.62m | |
| ILMN | Illumina, Inc. | -1.65% | 303.71 | 3.5% | $275.40m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.28% | 183.85 | 1.9% | $247.78m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.73% | 118.92 | 15.4% | $216.64m | |
| BPTH | Bio-Path Holdings, Inc. | -12.42% | 19.25 | 190.1% | $203.41m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.60% | 132.29 | 2.0% | $187.73m | |
| EXAS | Exact Sciences Corporation | 0.07% | 89.06 | 25.3% | $173.12m | |
| A | Agilent Technologies, Inc. | 0.66% | 79.51 | 1.6% | $122.76m | |
| IONS | Ionis Pharmaceuticals, Inc. | 0.18% | 79.04 | 8.3% | $109.28m | |
| INCY | Incyte Corporation | 0.80% | 86.02 | 2.5% | $93.70m |
Company Profile
Proteostasis Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF), and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA.